Related Experiment Video
Updated: Aug 23, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients - part III: age
Till Neumann1, T Woiwod, A Neumann
1Department of Cardiology, University of Duisburg-Essen, Medical School, Hufelandstr. 55, D-45122 Essen, Germany. till.neumann@uni-essen.de
Insights
Cardiovascular disease risk increases with age in HIV-infected patients, particularly due to metabolic changes. This highlights the need for proactive cardiovascular risk management in this growing population.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Growing concerns regarding elevated cardiovascular disease (CVD) rates in HIV-infected individuals.
- Antiretroviral therapy (ART) side effects are implicated in increased CVD risk.
- Age is a critical factor influencing cardiovascular health in HIV patients.
Purpose of the Study:
- To analyze the cardiovascular risk profile of HIV-infected patients across different age groups.
- To evaluate the probability of 10-year cardiovascular events in relation to patient age.
- To understand the impact of aging on cardiovascular health in the context of HIV infection.
Main Methods:
- Analysis of cardiovascular risk factors in 309 HIV-infected adults.
- Stratification of patients into four age groups: 18-30, 31-40, 41-50, and >50 years.
- Utilized the Framingham algorithm to assess the 10-year cardiovascular event probability.
Main Results:
- Significant age-related differences in lipid and glucose metabolism were observed.
- Total cholesterol, LDL-cholesterol, and triglyceride levels increased with age (p < 0.05).
- The 10-year cardiovascular event probability was substantially higher in older patients (20.5% in >50 group vs. 1.9% in 18-30 group; p < 0.01).
Conclusions:
- Cardiovascular event risk is significantly associated with age in HIV-infected patients.
- Increased lifespan due to effective ART necessitates addressing age-related cardiovascular risks.
- A future rise in cardiovascular events among HIV-infected patients is anticipated, requiring targeted interventions.
Objective:
In recent years, concerns have been growing about an elevated rate of cardiovascular diseases in HIV-infected patients due to side effects of antiretroviral therapy. The present study analyses the cardiovascular risk profile and the probability of cardiovascular events with regard to the age of HIV-infected patients.
Methods:
Cardiovascular risk factors of 309 HIV-infected adults were analysed. Patients were divided into four groups: 18-30 years (group 1), 31-40 years (group 2), 41-50 years (group 3), > 50 years (group 4). Overall 10-years probability for cardiovascular events was evaluated by the Framingham algorithm.
Results:
Differences between the groups were detected in cardiovascular risk factors including changes in lipid- and glucose metabolism. Lipid values increased with elevated age, such as total cholesterol concentration (Mean +/- SEM in group 1 vs. group 4: 4.71 +/- 0.20 to 6.36 +/- 0.21 mmol/L, p < 0.05), LDL-cholesterol concentration (2.86 +/- 0.17 vs. 4.17 +/- 0.21 mmol/L, p < 0.05) and triglyceride concentration (1.56 +/- 0.14 vs. 3.48 +/- 0.40 mmol/L, p < 0.05). HDL-cholesterol concentration did not show a significant difference (1.15 +/- 0.03 mmol/L). Glucose concentration increased with elevated age in HIV-infected patients (5.28 +/- 0.19 vs. 6.46 +/- 0.24 mmHg, p < 0.05), but there was no significant difference in HbA1c - concentration, blood pressure and smoking rate between the groups. The overall 10-years probability for cardiovascular events was higher in group 1 (median: 1.9%) than in group 4 (20.5%; p < 0.01).
Conclusions:
The risk of cardiovascular events is related to the age in HIV-infected patients. Therefore, an increased duration of life due to a more effective antiretroviral therapy will have a significant impact on the rate of cardiovascular events in this patient population. In the future, further increase of cardiovascular events in HIV-infected patients may be expected.
Related Concept Videos
Retrovirus Life Cycles
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

